上海家化(600315) - 2015 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months rose by 10.78% to CNY 4,617,561,352.08 year-on-year[8] - Net profit attributable to shareholders increased by 5.77% to CNY 760,751,080.33 compared to the same period last year[8] - Basic and diluted earnings per share both rose by 9.26% to CNY 1.18[8] - Total revenue for the first nine months of 2015 reached CNY 4,617,561,352.08, an increase of 10.7% compared to CNY 4,168,265,729.09 in the same period last year[29] - Operating profit for Q3 2015 was CNY 188,728,930.76, a decrease of 6.3% from CNY 202,186,952.79 in Q3 2014[30] - Net profit attributable to shareholders for the first nine months of 2015 was CNY 790,439,979.77, up 7.1% from CNY 737,837,574.61 in the same period last year[30] - The total profit for the first nine months of 2015 was CNY 1.04 billion, compared to CNY 898.55 million in the same period last year, an increase of 16.1%[33] Assets and Liabilities - Total assets increased by 19.24% to CNY 6,598,369,371.84 compared to the end of the previous year[7] - Net assets attributable to shareholders increased by 14.24% to CNY 4,346,577,496.82 compared to the end of the previous year[7] - The company's total liabilities increased to RMB 2,251,791,875.02 from RMB 1,728,427,196.35, marking a rise of about 30%[23] - Total assets as of Q3 2015 amounted to CNY 6,253,504,144.32, compared to CNY 5,161,131,762.15 at the end of the previous year, reflecting a growth of 21.1%[26] - Total liabilities increased to CNY 1,799,163,467.18, up from CNY 1,343,304,266.39, representing a rise of 33.9%[26] Cash Flow - Cash flow from operating activities decreased by 56.12% to CNY 394,937,757.08 compared to the same period last year[7] - The company reported a net cash flow from operating activities of CNY 394,937,757.08 for the first nine months[7] - The cash flow from operating activities for the first nine months of 2015 was CNY 4.60 billion, an increase from CNY 4.42 billion in the same period last year, reflecting a growth of 4.2%[36] - The net cash flow from operating activities for Q3 2015 was ¥394,937,757.08, a decrease of 56% compared to ¥899,948,047.78 in Q3 2014[37] - Total cash inflow from operating activities for the first nine months of 2015 was ¥2,279,513,807.21, down from ¥2,374,700,282.82 in the same period last year[41] Investments - Long-term equity investments decreased by 83.58% to ¥115,560,201.05, as a result of the transfer of equity in Jiangyin Tianjiang Pharmaceutical[13] - Cash outflow for investments surged by 983.76% to ¥2,869,080,100.00, reflecting increased term deposits[14] - The company received ¥1,312,046,660.30 from investment recoveries in the first nine months of 2015, compared to ¥423,500,000.00 in the same period last year[41] - The total cash outflow for investment activities in Q3 2015 was ¥3,280,888,581.53, compared to ¥278,691,860.39 in Q3 2014[42] Shareholder Information - The total number of shareholders at the end of the reporting period was not specified, but the report includes details on the top ten shareholders[11] - The company's equity attributable to shareholders reached RMB 4,346,577,496.82, up from RMB 3,804,904,626.49, reflecting an increase of approximately 14.3%[23] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[30]